Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • owomo
    Junior Member
    • May 2008
    • 8

    #1

    Statistical test for unbalanced data set

    Hi, guys,
    My interest is to ask whether a gene is differentially expressed between group A and group B.
    but the experiment design is unbalanced as follow:

    A1, A2, A3, B1_repeat1, B1_repeat2, B2_repeat1, B2_repeat2.

    So, group A contains 3 samples, but group B contains only two samples, and each have two biological replicates.

    I have used the edgeR to fit a generalized linear models (GLMs). But a review says that it may be not appropriate to manage the biological replicates in group B in this way.
    My questions are:
    What is the most proper way to manage the biological replicates? Is a mixed effect model suitable is this case?
    Thank your very much for you time, any suggestion would be greatly appreciated.
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    edgeR works fine for unbalanced designs. One question is what the repeats in group B represent. Are these re-runs of the same library (i.e., they represent a minimal batch effect) or were they made from a different library. Also, did the first try at samples B1 and B2 just produce crappy results or why else did you repeat them?

    Comment

    • owomo
      Junior Member
      • May 2008
      • 8

      #3
      Originally posted by dpryan View Post
      edgeR works fine for unbalanced designs. One question is what the repeats in group B represent. Are these re-runs of the same library (i.e., they represent a minimal batch effect) or were they made from a different library. Also, did the first try at samples B1 and B2 just produce crappy results or why else did you repeat them?
      Thank you for your reply. Sorry I didn't clarify my experiment.
      The replicates in group B is biological replicates, it is not re-runs of the same
      for example,
      In group 1, we have species A, species B, species C.
      In group 2, we have species D, with individual D1 and D2, and species E, with individual E1 and E2.
      We would like to test whether a gene is significantly differentially expressed between group1 (including species A, B, C) and group2 (including species D, E).
      So any suggestions? Thank you very much.
      Last edited by owomo; 10-08-2014, 05:12 PM.

      Comment

      • dpryan
        Devon Ryan
        • Jul 2011
        • 3478

        #4
        Right, I'm asking about B1_repeat1 vs. B1_repeat2. Are those actually biological replicates or are they technical replicates. If the latter, why did you bother producing them?

        Comment

        • owomo
          Junior Member
          • May 2008
          • 8

          #5
          Originally posted by dpryan View Post
          Right, I'm asking about B1_repeat1 vs. B1_repeat2. Are those actually biological replicates or are they technical replicates. If the latter, why did you bother producing them?

          Sorry, I edit my last thread again and hope it is clear now.

          In group 1, we have species A, species B, species C.
          In group 2, we have species D, with individual D1 and D2, and species E, with individual E1 and E2.

          So there are 2 sample in group 2, each with 2 biological replicates, while in group 1, we have 3 sample, but no replicates.

          1, dividual D1 and D2, individual E1 and E2 are biological replicates, not technical replicates.
          2, I wanna to test group 1 (including species A,B,C) Vs. group 2 (including species D, E).

          Many thanks for your time
          Last edited by owomo; 10-08-2014, 06:37 PM.

          Comment

          • owomo
            Junior Member
            • May 2008
            • 8

            #6
            OK, I think I can simplify this model as follows,
            group 1 have 3 biological replicates,
            group 2 have 2 biological replicates, but each with 2 technical replicates.
            for example:

            group exp
            A1 23
            A2 25
            A3 27
            B1.1 89
            B1.2 85
            B2.1 78
            B2.2 82

            So, how to manage the technical replicates in group 2?

            Thanks a lot
            Last edited by owomo; 10-09-2014, 12:38 AM.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
              by SEQadmin2



              CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

              Despite this, “CRISPR helped turn genome editing from a specialized technique into
              ...
              Yesterday, 11:01 AM
            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Yesterday, 02:55 AM
            0 responses
            9 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-24-2026, 12:17 PM
            0 responses
            12 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-23-2026, 11:41 AM
            0 responses
            13 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            24 views
            0 reactions
            Last Post SEQadmin2  
            Working...